share_log

Genvor to Participate in World Agri-Tech Innovation Summit in San Francisco

Genvor to Participate in World Agri-Tech Innovation Summit in San Francisco

Genvor將參加在舊金山舉行的世界農業技術創新峯會
Accesswire ·  02/27 08:31

Genvor Presenting as a Featured Startup at Leading Global AgTech Event

Genvor作爲特色初創公司亮相全球領先的農業科技盛會

CHAPEL HILL, NC / ACCESSWIRE / February 27, 2024 / Genvor Incorporated (OTCQB:GNVR) ("Genvor" or the "Company"), a developer of sustainable plant health solutions leveraging patented peptides, today announced that management will attend and present as a Featured Startup at the World Agri-Tech Innovation Summit taking place March 19-20, 2024 in San Francisco.

北卡羅來納州教堂山/ACCESSWIRE/2024 年 2 月 27 日/ Genvor 公司 (OTCQB: GNVR)(“Genvor” 或 “公司”)是利用專利肽開發可持續植物健康解決方案的開發商,今天宣佈,管理層將作爲特色初創公司出席並出席會議 世界農業技術創新峯會 將於 2024 年 3 月 19 日至 20 日在舊金山舉行。

World Agri-Tech brings together over 2,500 decision-makers among agri-food business, OEMs, food brands, growers, tech providers and investors for two days of high-level networking, strategic market intelligence and start-up discovery. With a focus on harnessing nature-based solutions to meet climate commitments, and successful paths for commercializing biological inputs, next-generation breeding, AI and automation, an outstanding speaking faculty uncovers the innovations and investment propelling new value creation in this sector.

World Agri-Tech彙集了來自農業食品企業、原始設備製造商、食品品牌、種植者、科技提供商和投資者的2,500多名決策者,進行爲期兩天的高層交流、戰略市場情報和初創企業發現。一位傑出的演講教師專注於利用基於自然的解決方案來履行氣候承諾,以及實現生物投入、下一代育種、人工智能和自動化的成功途徑,他們發現了推動該領域新價值創造的創新和投資。

Chad Pawlak, Chief Executive Officer of Genvor, plans to participate in one-on-one meetings with industry participants, investors and the media throughout the conference, and will give a presentation to attendees as a Featured Startup.

Genvor首席執行官查德·帕拉克計劃在整個會議期間參加與行業參與者、投資者和媒體的一對一會議,並將作爲特色初創公司向與會者發表演講。

World Agri-Tech Innovation Summit: Featured Startup Presentation
Date: March 19-20, 2024
Location: Marriott Marquis| San Francisco, California

世界農業技術創新峯會:初創企業精選演講
日期:2024 年 3 月 19 日至 20 日
地點:馬奎斯萬豪酒店 | 加利福尼亞州舊金山

For more information or to register for the event, please visit the conference website. To schedule a one-on-one meeting at the conference, please email your request to GNVR@mzgroup.us or call Lucas Zimmerman at (949) 259-4987.

欲了解更多信息或報名參加此次活動,請訪問 會議網站。要在會議上安排一對一的會議,請將您的請求通過電子郵件發送至 GNVR@mzgroup.us 或致電 (949) 259-4987 致電盧卡斯·齊默爾曼。

About Genvor

關於 Genvor

Genvor Incorporated (OTCQB:GNVR) is a developer of sustainable plant health solutions, with a portfolio of patented peptides to provide crops with anti-pathogen and enhanced nutritional properties through next-generation biological foliar application as well as transgenic seed traits. Supported by globally renowned scientists and a USDA partnership, Genvor leverages its licensing-first business model with active trait developments underway for a variety of crops including corn, citrus, rice, cotton, soybean, flax, and potato. To learn more, please visit or follow us on LinkedIn, Facebook or Instagram.

Genvor 公司 (OTCQB: GNVR) 是可持續植物健康解決方案的開發商,其專利肽產品組合可通過下一代生物葉面應用和轉基因種子性狀爲作物提供抗病原體和增強的營養特性。在全球知名科學家和美國農業部合作伙伴關係的支持下,Genvor利用其許可優先的商業模式,正在積極開發包括玉米、柑橘、水稻、棉花、大豆、亞麻和馬鈴薯在內的各種作物的性狀。要了解更多信息,請訪問 或者關注我們 領英Facebook 要麼 Instagram

Forward-Looking Statements

前瞻性陳述

This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements include information about management's view of the Company's future expectations, plans and prospects, including future business opportunities or strategies and are generally preceded by words such as "may," "believe," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of known and unknown risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. Certain of these risk factors and others are included in documents the Company files with the Securities and Exchange Commission, including but not limited to, the Company's Annual Report on Form 10-K, as well as subsequent reports filed with the Securities and Exchange Commission.

本新聞稿可能包含1933年《證券法》第27A條和1934年《證券交易法》第21E條所指的前瞻性陳述。前瞻性陳述包括有關管理層對公司未來預期、計劃和前景的看法的信息,包括未來的商業機會或戰略,前面通常以 “可能”、“相信”、“未來”、“計劃” 或 “計劃”、“將” 或 “應該”、“預期”、“預期”、“最終” 或 “預測” 等詞語開頭。請注意,此類陳述存在許多已知和未知的風險和不確定性,這些風險和不確定性可能導致未來的情況、事件或結果與前瞻性陳述中的預測存在重大差異,包括由於各種因素,實際業績可能與前瞻性陳述中的預測存在重大差異的風險。其中某些風險因素和其他風險因素包含在公司向美國證券交易委員會提交的文件中,包括但不限於公司的10-K表年度報告以及隨後向美國證券交易委員會提交的報告。

Investor Relations Contact:

投資者關係聯繫人:

Lucas A. Zimmerman
Managing Director
MZ Group - MZ North America
(949) 259-4987
GNVR@mzgroup.us

盧卡斯·A·齊默爾曼
董事總經理
MZ 集團-MZ 北美
(949) 259-4987
GNVR@mzgroup.us

SOURCE: Genvor Incorporated

來源:Genvor 公司


声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論